Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.deccanhealthcare.co.in / www.beyoungstore.com | |
Market Cap | 68.24 Cr. | |
Enterprise Value(EV) | 67.91 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.18 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 187.47 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 38.37 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 45.35 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 0.74 | Calculated using Price: 33.49 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.04 Cr. | 20,376,180 Shares |
FaceValue | 10 | |
About Deccan Health Care Ltd. | ||
The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc. |
1 Day |
|
+11.12% |
1 Week |
|
+18.10% |
1 Month |
|
+6.71% |
3 Month |
|
-14.59% |
6 Month |
|
-0.06% |
1 Year |
|
-17.30% |
2 Year |
|
+18.14% |
5 Year |
|
|
10 Year |
|
3 years | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.51 | 0.42 | 0.46 | |
Return on Capital Employed (%) | 0.81 | 0.89 | 0.78 | |
Return on Assets (%) | 0.42 | 0.35 | 0.39 |
Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 77 | 77 | 82 | 82 | |
Non Curr. Liab. | 3 | 3 | 3 | 3 | |
Curr. Liab. | 13 | 10 | 12 | 17 | |
Minority Int. | |||||
Equity & Liab. | 92 | 91 | 97 | 102 | |
Non Curr. Assets | 26 | 23 | 21 | 20 | |
Curr. Assets | 66 | 68 | 76 | 82 | |
Misc. Exp. not W/O | |||||
Total Assets | 92 | 91 | 97 | 102 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 34 | 33 | 45 | |
Other Income | 0 | 0 | 0 | |
Total Income | 34 | 33 | 45 | |
Total Expenditure | -32 | -28 | -43 | |
PBIDT | 2 | 6 | 2 | |
Interest | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | |
Exceptional Items | -3 | |||
PAT | 0 | 0 | 0 | |
Minority Interest | ||||
Share Associate | ||||
Other Related Items | ||||
Consolidated Net Profit | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -1 | -7 | |
Cash Fr. Inv. | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 5 | |
Net Change | 0 | -1 | -1 | |
Cash & Cash Eqvt | 3 | 3 | 1 |
Sun, 12 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find attached newspaper publication of Financial Results for the quarter ended September 30 2023. |
Sat, 11 Nov 2023
Financial Results For The Quarter Ended September 30 2023 Financial Results for the quarter ended September 30 2023 |
Sat, 11 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. November 11 2023 And Submission Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended September 30 2023 With reference to our Intimation vide letter dated Friday November 03 2023 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Saturday November 11 2023 through Video Conferencing/OAVM have Inter-alia;1. Considered and Approved the Standalone Unaudited Financial Results of the Company for the quarter ended September 30 2023 along with the Limited Review Report.2. Considered and Approved the Consolidated Unaudited Financial Results of the Company for the quarter ended on September 30 2023 along with the Limited Review Report.The Board Meeting commenced at 11:30 AM and concluded at 11:50 AM |
Mon, 11 Dec 2023 |
|
|
|
|
|